Skip to main content
CAR T-cell benefit in lenalidomide-refractory myeloma
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
CAR T-cell benefit in lenalidomide-refractory myeloma
User login
Username
Password
Reset your password
Concept
Lead
score
Multiple Myeloma
1
1
Biologic Therapy
0
0.99
CAR-T
0
0.88
Immunomodulator
0
0.51
Refractory
0
0.36
Antigens
0
0.1
Cancer
0
0.1
Proteasome Inhibitor
0
0.1
Quality of Life
0
0.09
Toxicology
0
0.08
Peripheral Neuropathy
0
0.07
Specialty
Lead
score
Hematology-Oncology
1
1
Allergy & Clinical Immunology
0
0.9
Edit Tags